Trisindoline 5 Compound Inhibits Human Breast Cancer Stem Cell Formation by Downregulating the BCL-2 Gene Expression. CBS Int. Journal 2022, 1 (2), 65-69. https://doi.org/10.59278/cbs.v1i2.19.